NEW YORK, Sept. 3, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of Abbott Laboratories’ securities AWAY between February 19, 2021 and June 8, 2022, both dates inclusive (the “Class Period”). If you want to appear as lead plaintiff, you must call the court not later than October 312022.

SO WHAT: If you purchased Abbott securities during the Class Period, you may be entitled to compensation without payment of expenses or costs through a contingency fee arrangement.

WHAT TO DO NEXTT: To join the Abbott Class Action, go to https://rosenlegal.com/submit-form/?case_id=8453 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] or [email protected] for information about the Class Action. A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court not later than October 312022. A lead plaintiff is a representative party acting on behalf of other group members in conducting the litigation.

WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Be wise in choosing a lawyer. The Rosen Law Firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivatives litigation. Rosen Law Firm has achieved the largest-ever settlement of a securities class action lawsuit against a Chinese company. Rosen Law Firm was ranked #1 in 2017 by ISS Securities Class Action Services for the number of securities class action settlements. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020 founding partner Laurence Rosen was appointed by Law360…